Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.
about
Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorEffects of Peptide on NK cell-mediated MHC I recognitionEvasion from NK cell-mediated immune responses by HIV-1Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathyKIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motifPeptide antagonism as a mechanism for NK cell activation.HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variationHLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell functionBalancing natural killer cell activation through paired receptors.Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I moleculeThe interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitopeSequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell functionHuman-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.Host genes important to HIV replication and evolution.Innate immune control of HIV.A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsRecognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysisDistinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.The Yin and Yang of HLA and KIR in human diseaseStructural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.KIR and disease: a model system or system of models?Controlling natural killer cell responses: integration of signals for activation and inhibition.Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy.Structural basis for recognition of cellular and viral ligands by NK cell receptors.HIV-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversification.Role of KIR3DS1 in human diseases.Endoplasmic reticulum aminopeptidase 1 function and its pathogenic role in regulating innate and adaptive immunity in cancer and major histocompatibility complex class I-associated autoimmune diseases.Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.NK cells: tuned by peptide?The killer-cell immunoglobulin-like receptors of macaques.Missing or altered self: human NK cell receptors that recognize HLA-C.HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.Octapeptide but not nonapeptide from HIV-1 p24gag protein upregulates cell surface HLA-C expression.Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing.Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.Natural killer cell-mediated lysis of autologous cells modified by gene therapy.
P2860
Q24544012-78DB5ECB-E9CF-4A7F-A273-91148599DFEAQ24671977-4A8B0584-333B-4AA4-856F-CDFFAAA9B753Q26822893-5E212E5B-D0B4-45E9-9165-87A004BAB30AQ26864489-CF9237B2-02C1-4582-8287-EDEFD836C249Q30252783-04E8DBB7-85E4-4F25-93DB-DDF9BEE53667Q33672480-FF69C15F-7A78-4A99-809E-CC723A281C5DQ33845247-F0445B05-02B1-4ACF-9E30-EEC77D4BF2ABQ33851496-2F4BD7FF-DB5A-4EFC-ABD6-F4E3D69D1009Q33933479-EDFCA1C4-9CAC-4407-BB02-99C413A736D0Q34190667-74DB0390-B95B-4E12-83E5-1E51A9670E33Q34341384-9F5951BA-BFB9-4CA4-B416-32ED20230694Q34465877-FB6D8B35-8426-41AB-A3D8-6CB16C83520AQ34482335-70AA3584-D5C4-46AA-99B1-0611960D5A57Q34810328-F755ED6A-E8A5-4EE7-B4DA-0AB90A78D9A6Q35678598-23D6A8BF-EAED-4E4E-954F-71616368816BQ35701077-57F8D8C7-5E7A-42B8-9E5D-75F8FA8052C1Q35853016-08EFF206-40B1-401E-8162-891EBD5E162DQ36065864-6E2B43A5-8E6F-492B-A9B2-EDA1EFAB9F28Q36229149-2204D0D5-EF37-436B-91C8-BDC55FAC6E12Q36400442-10F26758-6F39-402B-B057-CAC341F93442Q36407362-C5D0A829-5B9D-47BF-8DEC-9DA23D7F2E61Q36410540-221F1016-39AA-4655-A991-D46C67F6447EQ36493811-F89AA085-70C5-4645-A48A-48BCB6AFA8F1Q36652201-9D520676-F5C9-4B6D-AE11-01597D2DAA23Q37404156-F7708CAB-53E2-4318-8A07-019859F196D6Q37616324-9C01EC0B-FDBD-4425-9477-B39B047D70BEQ37678862-5B0C9667-4932-461D-851B-E1AF154E0866Q37734787-88707C38-1405-4C03-9B66-4840AC6A619CQ38057745-8208C3DA-E618-463E-ADA5-A9BE26CFACA4Q38234401-2E033F18-9FF9-4ECA-816F-44CE90E64440Q38320280-85016C5B-83E9-46D6-A950-80D670239B1FQ38568874-418B2CAD-40A6-4FC3-B2B5-944806295FBDQ38568884-0BFF6F94-DC4B-4B7C-B2E3-BC7F38392ACDQ38568886-08EA4A01-CA65-41EE-9794-4218A6A22D5EQ39427580-641CA3F7-CA60-4B5F-8BC7-D13E4DD553A6Q40201364-87860BDD-33EE-439E-B0F9-637C02B6480FQ40764807-FCEC6577-8644-4D5A-90B3-F103DF090631Q40845256-C04E3C90-9126-436A-B357-DA66B88A8413Q41731150-84371CC8-D368-498F-A636-0AF6A3B12566Q41853967-ED85E6DB-00DA-4EB2-BE7A-18474D4049E9
P2860
Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@ast
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@en
type
label
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@ast
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@en
prefLabel
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@ast
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@en
P2093
P2860
P356
P1476
Peptides isolated from HLA-Cw* ...... al killer cell-mediated lysis.
@en
P2093
Coligan JE
Zappacosta F
P2860
P304
P356
10.1073/PNAS.94.12.6313
P407
P577
1997-06-01T00:00:00Z